Physician profile
Michael Setzen
NPI 1356381628
$69,415.93
in general payments reported to CMS, 2019-2025
18 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $1,177 · 2021: $395 · 2022: $18K · 2023: $3,706 · 2024: $6,484 · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Food and Beverage: $4,563 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,117.00 |
| Food and Beverage | $4,562.79 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $40,343.68 | 2020-2025 | |
| Stryker Corporation | $18,848.96 | 2019-2024 | Xpress Ent Dilation System, Scopis Ent, Orthomap |
| Regeneron Pharmaceuticals, INC. | $5,141.81 | 2024 | Dupixent |
| Medtronic USA, INC. | $950.00 | 2020 | |
| Optinose US, INC. | $796.17 | 2019-2025 | |
| Neurent Medical Limited | $792.15 | 2022-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Genzyme Corporation | $705.29 | 2023-2025 | |
| Intersect Ent, INC. | $489.94 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $396.07 | 2023-2025 | Dupixent |
| Medtronic, INC. | $273.53 | 2022-2024 | Propel |
| Genentech USA, INC. | $150.46 | 2024 | Xolair |
| Inspire Medical Systems, INC. | $150.10 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $143.68 | 2024-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $98.99 | 2023 | |
| Merck Sharp & Dohme LLC | $44.60 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $44.32 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Acclarent, INC | $25.82 | 2019-2022 | |
| Chiesi USA, INC. | $20.36 | 2025 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Setzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.